Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Merck Sharp and Dohme Corp.
WARNING LETTER
•Merck Sharp and Dohme Corp.•June 15, 2011

Merck Sharp and Dohme Corp. – FDA Warning Letter, Jun 15, 2011

Record Details

This FDA Warning Letter, Ref: 12-HFD-47-02-01, dated February 17, 2012, addresses Merck Sharp and Dohme Corp. for failing to comply with milestone dates for a required postmarketing study (PMR) concerning Januvia® and Janumet® (NDAs 021995 and 022044). The PMR was mandated to investigate a serious risk signal of acute pancreatitis, including necrotizing forms, associated with sitagliptin use.

The violation stems from noncompliance with a previously agreed-upon timetable for PMRs 1602 and 1603, specifically missing the June 15, 2010, final protocol submission and June 15, 2011, final report submission dates. Merck's attempt to satisfy the PMR with an independently conducted, investigator-initiated study was deemed insufficient as its protocol was not FDA-reviewed or agreed upon prior to initiation, and a final study report was not provided.

The FDA determined Merck failed to demonstrate good cause for these delays, which were over 20 months for protocol submission and over 8 months for the final report. This noncompliance violates section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act, rendering the product misbranded under section 502(z).

The

Company
Merck Sharp and Dohme Corp.
Inspection date
June 15, 2011
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Leslie K. Ball
  • Hee (Sheila) Lianos
View Company Profile

ID · c825081f-7d31-4c41-b074-ca0220b9dc4f

Violation Codes3
21 U.S.C. 35521 U.S.C. 352(z)21 U.S.C. 333(f)(4)

Full citation text and observation details available on the Dashboard.

Other documents for Merck Sharp and Dohme Corp.
  • EIR - 2013-08-16August 16, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Merck Sharp and Dohme Corp.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.